Targeting the tumor vascular supply with vascular disrupting agents

بواسطة Soo, R.A.
منشور في 2014

Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapse

بواسطة Zee, Y.K., Soo, R.A.
منشور في 2014

Systemic therapies for pancreatic cancer - the role of pharmacogenetics

بواسطة Soo, R.A., Yong, W.-P., Innocenti, F.
منشور في 2014

Rare subtypes of adenocarcinoma of the lung

بواسطة Ou, S.-H.I., Kawaguchi, T., Soo, R.A., Kitaichi, M.
منشور في 2014

Lung cancer response to gefitinib, then erlotinib, then gefitinib again

بواسطة Wong, A.S., Seto, K.-Y., Chin, T.-M., Soo, R.A.
منشور في 2014

A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians

بواسطة Peng, S., Ying, A.F., Tai, B.C., Soo, R.A.
منشور في 2021

ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway

بواسطة Ou, S.-H.I., Tan, J., Yen, Y., Soo, R.A.
منشور في 2014

Clinical pharmacology and pharmacogenetics of gemcitabine

بواسطة Wong, A., Soo, R.A., Yong, W.-P., Innocenti, F.
منشور في 2014

Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer

بواسطة Chin, L.P., Soo, R.A., Soong, R., Ou, S.-H.I.
منشور في 2014

Poster: Modelling the tumor shrinkage pharmacodynamics with BlenX

بواسطة Lecca, P., Kahramanogullari, O., Morpurgo, D., Priami, C., Soo, R.A.
منشور في 2014

Modelling and estimating dynamics of tumor shrinkage with Blenx and KinferX

بواسطة Lecca, P., Kahramanoǧullari, O., Morpurgo, D., Priami, C., Soo, R.A.
منشور في 2014

Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET...

بواسطة Ou, S.-H.I, Soo, R.A, Kubo, A, Kawaguchi, T, Ahn, M.-J
منشور في 2020

The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer

بواسطة Cho, B.C., Kim, J.H., Soo, R.A., Yang, C.-H.
منشور في 2014

Targeted therapy at the end of life for patients with lung cancer

بواسطة Wong, A.S., Teo, C., Lim, S.-W., Wong, E., Soo, R.A., Chan, N.
منشور في 2014

Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma

بواسطة Lim, S.M., Kim, H.R., Shim, H.S., Soo, R.A., Cho, B.C.
منشور في 2014

How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?

بواسطة Wong, A.S., Seto, K.-Y., Ang, B., Wong, E., Chin, T.-M., Nga, M.-E., Soo, R.A.
منشور في 2014

Prognostic significance of immune cells in non-small cell lung cancer: Meta-analysis

بواسطة Soo, R.A, Chen, Z, Yan Teng, R.S, Tan, H.-L, Iacopetta, B, Tai, B.C, Soong, R
منشور في 2020

Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effect

بواسطة Wang, L.-Z., Yong, W.-P., Soo, R.-A., Lee, S.-C., Soong, R., Lee, H.-S., Goh, B.-C.
منشور في 2014

Does saturable formation of gemcitabine triphosphate occur in patients?

بواسطة Tham, L.-S., Wang, L.-Z., Soo, R.A., Lee, H.-S., Lee, S.-C., Goh, B.-C., Holford, N.H.G.
منشور في 2014

Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy

بواسطة Soo, R.A., Kawaguchi, T., Loh, M., Ou, S.-H.I., Shieh, M.P., Cho, B.-C., Mok, T.S., Soong, R.
منشور في 2014